Trial Profile
Jikei-Evaluation of basal insulin analogue on (nocturnal) glycaemic variability with continuous glucose monitoring -existing basal insulin analogue versus Tresiba; insulin degludec - a new basal insulin analogue, in basal-bolus treatment in type 1 diabetes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Oct 2016
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary) ; Insulins
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms JET-1
- 19 Oct 2016 Status changed from recruiting to completed according to results presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes
- 16 Sep 2016 Results presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes
- 01 Jul 2014 New trial record